Company intelligence / Profile preview

EyeDura Therapeutics, Inc.

Palm Beach Gardens, Florida, United Statesstreetinsider.com ↗

Ownership: Private
Development stage: Preclinical

Overview

EyeDura is developing preservative-free sustained release eye drops with a proprietary topical drug delivery platform. Their drug formulation is lipid-based, has high viscosity, and integrates into the lipid phase of the tear film with zero-order kinetics drug release.

Therapeutic areas: Ophthalmology
Modalities: Lipid-based drug formulations
Industry: Biotech

Drug pipeline

1 asset

EYED-002

Beyond the preview

Go deeper on EyeDura Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EyeDura Therapeutics, Inc..

Explore the full profile